SCHEMBL3973587

SCHEMBL3973587

NC(=O)c1ccc(-c2ccccc2)c(OCCCl)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 2/20 0.48
MKNK2 Q9HBH9 1/20 0.48
EGFR P00533 1/20 0.47
CYP11B1 P15538 2/20 0.46
CYP11B2 P19099 2/20 0.46
PARP10 Q53GL7 1/20 0.45
CHEK2 O96017 1/20 0.44
LMNA P02545 2/20 0.43
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43
RXRA P19793 1/20 0.43
RXRB P28702 1/20 0.43
RXRG P48443 1/20 0.43
L3MBTL1 Q9Y468 3/20 0.42
TDP1 Q9NUW8 2/20 0.42
MAPK1 P28482 3/20 0.42
ROCK2 O75116 1/20 0.42
ROCK1 Q13464 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3973609 0.96 MKNK1 (0.47) MKNK1MKNK2EGFRCYP11B1CYP11B2
SCHEMBL3974889 0.87 MKNK1 (0.47) MKNK1MKNK2EGFRCYP11B1CYP11B2
SCHEMBL3972289 0.86 MKNK1 (0.46) MKNK1MKNK2EGFRCYP11B1CYP11B2
SCHEMBL9306503 0.84 THRA (0.56) MKNK1MKNK2LMNAPDE4APDE4B
SCHEMBL3975202 0.84 PARP10 (0.42) MKNK1MKNK2PARP10PDE4DL3MBTL1
SCHEMBL5227439 0.83 RXRA (0.59) CYP11B1CYP11B2PARP10RXRARXRB
SCHEMBL2967356 0.79 MKNK1 (0.72) MKNK1MKNK2EGFRLMNAPDE4A
Methane SCHEMBL21358430 0.78 MKNK1 (0.70) MKNK1MKNK2EGFRLMNAPDE4A
SCHEMBL31696706 0.77 EGFR (0.53) EGFRCYP11B1CYP11B2LMNAPDE4A
SCHEMBL30556643 0.76 CHEK2 (0.44) MKNK1MKNK2EGFRCHEK2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054383-A2 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS SmithKline Beecham Corporation (US) 2009-05-06 EP disclosed
WO-2008021849-A2 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS SMITHKLINE BEECHAM CORPORATION (US) 2008-02-21 WO disclosed